This observational study aims to understand and potentially prevent chemotherapy-induced peripheral neuropathy (CIPN), a condition causing nerve damage and pain, in people with breast cancer. Researchers will use an Electroencephalogram (EEG) to measure your brain's electrical activity before and during chemotherapy. For some participants, the study will also test an experimental device called a closed-loop brain-computer interface (clBCI) to see if it can help prevent CIPN pain. The study is looking for 45 participants who are 18 or older, have breast cancer, can understand English, and are willing to come to MD Anderson for imaging. The main goal is to track safety and any side effects throughout the study, which is expected to last about one year. The current recruitment status is unclear.

Study design

This is an observational study with an unclear status, planning to enroll 45 participants. It is not specified if it is randomized or blinded.

What's involved

You would have an EEG before chemotherapy and then monthly for up to six measurements. You would also need to come to MD Anderson for these imaging sessions.

Compensation

Not stated in the trial record.

Follow-up

Your safety and any adverse events will be measured throughout the study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.